{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:14:21Z","timestamp":1790421261507,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.coph.2015.06.006","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T04:33:34Z","timestamp":1435725214000},"page":"18-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Antimicrobial treatment of bacterial infections in frail elderly patients: the difficult balance between efficacy, safety and tolerability"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6966-7167","authenticated-orcid":false,"given":"Federico","family":"Pea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2015.06.006_sbref0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.1254405","article-title":"Economic and social implications of aging societies","volume":"346","author":"Harper","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.coph.2015.06.006_bib0010","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s12603-013-0039-2","article-title":"Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Societe Francaise de Geriatrie et de Gerontologie) Workshop\u2014Athens, January 20\u201321, 2012","volume":"17","author":"Berrut","year":"2013","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.coph.2015.06.006_bib0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00228-012-1387-2","article-title":"Medication prescribing in frail older people","volume":"69","author":"Hubbard","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.coph.2015.06.006_bib0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/clpt.2011.258","article-title":"High-risk prescribing and incidence of frailty among older community-dwelling men","volume":"91","author":"Gnjidic","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2015.06.006_bib0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/11587200-000000000-00000","article-title":"Criteria for drug selection in frail elderly persons","volume":"28","author":"Huisman-Baron","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.coph.2015.06.006_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/11597870-000000000-00000","article-title":"Antimicrobial prescribing in hospitalized adults stratified by age: data from the ESAC point-prevalence surveys","volume":"29","author":"Zarb","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.coph.2015.06.006_sbref0035","first-page":"473","article-title":"Treatment options for community-acquired pneumonia in the elderly people","volume":"13","author":"Petrosillo","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.coph.2015.06.006_bib0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11739-012-0796-7","article-title":"Pneumonia in frail older patients: an up to date","volume":"7","author":"Falcone","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.coph.2015.06.006_bib0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2165\/11591980-000000000-00000","article-title":"Elderly patients with community-acquired pneumonia: optimal treatment strategies","volume":"28","author":"Thiem","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.coph.2015.06.006_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2049936113518041","article-title":"Management of community-acquired pneumonia in older adults","volume":"2","author":"Simonetti","year":"2014","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.coph.2015.06.006_bib0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rmed.2014.10.018","article-title":"Managing CAP patients at risk of clinical failure","volume":"109","author":"Welte","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.coph.2015.06.006_sbref0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/cis414","article-title":"Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"55","author":"Asadi","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coph.2015.06.006_bib0065","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1469-0691.2012.03838.x","article-title":"Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials","volume":"19","author":"Skalsky","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.coph.2015.06.006_bib0070","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pharmthera.2009.10.011","article-title":"Prediction of pharmacokinetic drug\u2013drug interaction caused by changes in cytochrome P450 activity using in vivo information","volume":"125","author":"Hisaka","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2015.06.006_bib0075","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2165\/00003088-200140110-00004","article-title":"Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions","volume":"40","author":"Pea","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.coph.2015.06.006_sbref0080","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-158-12-201306180-00004","article-title":"Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study","volume":"158","author":"Patel","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coph.2015.06.006_sbref0085","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1503\/cmaj.140950","article-title":"Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4","volume":"187","author":"Li","year":"2015","journal-title":"CMAJ"},{"key":"10.1016\/j.coph.2015.06.006_bib0090","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1124\/dmd.106.014407","article-title":"The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3","volume":"35","author":"Seithel","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.coph.2015.06.006_bib0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.amjmed.2012.02.022","article-title":"Emphasizing statin safety in the hospitalized patient: a review","volume":"125","author":"Leung","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.coph.2015.06.006_bib0100","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/imj.12464","article-title":"Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin","volume":"44","author":"Page","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.coph.2015.06.006_bib0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccl.2007.12.010","article-title":"Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly","volume":"26","author":"Jacobs","year":"2008","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.coph.2015.06.006_bib0110","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/archinte.1982.00340210032005","article-title":"Bleeding in patients with infections. Are antibiotics helping or hurting?","volume":"142","author":"Hochman","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.coph.2015.06.006_sbref0115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.amjmed.2014.01.044","article-title":"Serious bleeding events due to warfarin and antibiotic co-prescription in a cohort of veterans","volume":"127","author":"Lane","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.coph.2015.06.006_bib0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjmed.2011.08.014","article-title":"Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults","volume":"125","author":"Baillargeon","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.coph.2015.06.006_bib0125","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jamainternmed.2014.1615","article-title":"Supratherapeutic international normalized ratios in warfarin-treated patients who receive a highly potentiating antimicrobial course","volume":"174","author":"Daniels","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.coph.2015.06.006_bib0130","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1160\/TH13-09-0723","article-title":"Risk of bleeding and antibiotic use in patients receiving continuous phenprocoumon therapy. A case\u2013control study nested in a large insurance- and population-based German cohort","volume":"111","author":"Abbas","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.coph.2015.06.006_bib0135","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMcp1013127","article-title":"Clinical practice. Glycemic management of type 2 diabetes mellitus","volume":"366","author":"Ismail-Beigi","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2015.06.006_bib0140","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/jgs.12381","article-title":"Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study","volume":"61","author":"Solini","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.coph.2015.06.006_bib0145","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2009.460","article-title":"Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus","volume":"301","author":"Whitmer","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2015.06.006_bib0150","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2015.06.006_bib0155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/clpt.2010.74","article-title":"Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide","volume":"88","author":"Schelleman","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2015.06.006_bib0160","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2165\/00003088-200746120-00004","article-title":"Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies","volume":"46","author":"Eberl","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.coph.2015.06.006_bib0165","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bcp.2008.11.019","article-title":"The insulinotropic effect of fluoroquinolones","volume":"77","author":"Ghaly","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2015.06.006_sbref0170","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jamainternmed.2014.3293","article-title":"Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas","volume":"174","author":"Parekh","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.coph.2015.06.006_sbref0175","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/cid\/cit439","article-title":"Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan","volume":"57","author":"Chou","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coph.2015.06.006_bib0180","doi-asserted-by":"crossref","DOI":"10.1007\/s11255-015-1010-4","article-title":"Are currently GFR estimating equations and standard Kt\/V value adequate for advanced chronic kidney disease (CKD) frail elderly patients?","author":"Musso","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.coph.2015.06.006_bib0185","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ageing\/afu023","article-title":"Aminoglycosides use in patients over 75 years old","volume":"43","author":"Fraisse","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/j.coph.2015.06.006_bib0190","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/CIA.S50238","article-title":"Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia","volume":"8","author":"Mizokami","year":"2013","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.coph.2015.06.006_bib0195","doi-asserted-by":"crossref","DOI":"10.1007\/s40264-013-0089-8","article-title":"Tendon injury and fluoroquinolone use: a systematic review","author":"Stephenson","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.coph.2015.06.006_bib0200","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.clinthera.2014.09.020","article-title":"Neurotoxicity with antimicrobials in the elderly: a review","volume":"36","author":"Mattappalil","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.coph.2015.06.006_bib0205","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archinte.165.7.790","article-title":"Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients","volume":"165","author":"Corsonello","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.coph.2015.06.006_bib0210","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.7754\/Clin.Lab.2014.131110","article-title":"Evaluation of MDRD, Cockcroft-Gault, and CKD-EPI formulas in the estimated glomerular filtration rate","volume":"60","author":"Inal","year":"2014","journal-title":"Clin Lab"},{"key":"10.1016\/j.coph.2015.06.006_sbref0215","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40266-014-0187-z","article-title":"The use of estimated glomerular filtration rate for dose adjustment of medications in the elderly","volume":"31","author":"Elinder","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.coph.2015.06.006_bib0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkr442","article-title":"Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis","volume":"67","author":"Cataldo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.coph.2015.06.006_bib0225","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/CCM.0000000000000514","article-title":"Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis","volume":"42","author":"Hanrahan","year":"2014","journal-title":"Crit Care Med"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489215000764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489215000764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T03:22:09Z","timestamp":1537500129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489215000764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":45,"alternative-id":["S1471489215000764"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2015.06.006","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial treatment of bacterial infections in frail elderly patients: the difficult balance between efficacy, safety and tolerability","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2015.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}